HTG Molecular Diagnostics Inc (HTGM) Stock
HTGM is no longer traded. HTG Molecular Diagnostics was delisted from the Nasdaq in August 2023.
Prices on this page are historical; the last trade was August 16, 2023 at $0.34.
HTG Molecular Diagnostics stock price history
HTGM final trading statistics
- Final close
- $0.34
- Final trading day
- Aug 16, 2023
- Market cap at delisting
- $763.9K
- Shares outstanding
- 2.21M
- Final 52-week range
- $0.20 – $13.80
- Avg. volume (final 3 mo.)
- 119,892
- All-time high (split-adj.)
- $568944.00 · Jun 2015
- All-time low (split-adj.)
- $0.30 · Jul 2023
- Return since IPO
- -100.0%
- Beta
- 0.99
- Book value / share
- $0.21
- Price / book
- 1.61
HTG Molecular Diagnostics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $6.37M | -$21.6M | -$25.59 |
| FY2021 | $8.91M | -$17.1M | -$32.88 |
| FY2020 | $8.55M | -$20.9M | -$52.56 |
| FY2019 | $19.20M | -$19.3M | -$93.60 |
| FY2018 | $21.50M | -$16.5M | -$108.00 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About HTG Molecular Diagnostics Inc
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
HTG Molecular Diagnostics stock FAQ
What happened to HTG Molecular Diagnostics stock?
HTG Molecular Diagnostics stock was delisted from the Nasdaq. Its final close was $0.34 on August 16, 2023.
Is HTGM stock still trading?
No. HTGM was delisted from the Nasdaq in August 2023 and no longer trades on a U.S. exchange.
What was the last price of HTGM stock?
HTGM closed at $0.34 on its final trading day, August 16, 2023, for a market value of about $763.9K.
What were HTG Molecular Diagnostics's revenue and earnings in its last full fiscal year?
HTG Molecular Diagnostics reported revenue of $6.37M and net income of -$21.6M in fiscal 2022, its last full year as a public company.
When did HTG Molecular Diagnostics go public?
HTG Molecular Diagnostics Inc stock began trading on May 6, 2015.